AdaptHealth Corp. AHCO

FY2025 · ended Dec 31, 2025 · Revenue $3.24B, -0.5% YoY · Filed Feb 24, 2026

AdaptHealth Corp. (AHCO) files with the SEC under industry code 8082, Services-Home Health Care Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.2 billion and a net loss of $70.8 million. Free cash flow was $219.4 million.

Revenue (TTM)
$3.44B
+21.4% vs year-ago TTM
Net income (TTM)
$-406.73M
-594.6% vs year-ago TTM
Operating cash flow (TTM)
$578.80M
+1.7% vs year-ago TTM
Free cash flow (TTM)
$81.92M
-61.6% vs year-ago TTM
EPS (TTM)
$-3.03
-649.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
135.91M
+0.8% vs prior year
Net cash
$-1.80B
FY 2025
Operating margin
-9.6%
FY 2026

Company profile

Industry
Services-Home Health Care Services (SIC 8082)
Listed as
AHCO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Conshohocken, PA
SEC filer status
Large accelerated filer
SEC CIK
1725255
Former names
DFB Healthcare Acquisitions Corp. (until Nov 8, 2019)

Other Services-Home Health Care Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$3.2B
$3.3B
$3.2B
$3.0B
$2.5B
Operating income
$90.9M
$263.7M
-$598.4M
$190.4M
$225.6M
Net income
-$70.8M
$90.4M
-$678.9M
$69.3M
$156.2M
Diluted EPS
-$0.52
$0.61
-$5.31
$0.33
$0.67
Operating cash flow
$601.8M
$541.8M
$480.7M
$373.9M
$275.7M
Free cash flow
$219.4M
$235.8M
$143.2M
-$17.6M
$72.4M
Total assets
$4.3B
$4.5B
$4.5B
$5.2B
$5.3B
Total liabilities
$2.8B
$2.9B
$3.0B
$3.1B
$3.2B
Stockholders' equity
$1.5B
$1.6B
$1.5B
$2.2B
$2.1B
Cash and investments
$106.1M
$109.7M
$77.1M
$46.3M
$149.6M
Total debt
$1.9B
$2.1B
$2.3B
$2.3B
$2.4B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2026 Sep 3, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Material agreement
Jul 20, 2026 Jul 19, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.